These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 15278557)

  • 1. Duration of action of supplemental doses of vecuronium is related to the duration after the initial dose.
    Otagiri T; Narita M; Nishizawa M; Nishimura C
    J Anesth; 1992 Apr; 6(2):138-44. PubMed ID: 15278557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of the dose-response and recovery time course of vecuronium and atracurium in anesthetized chinese adult patients.
    Xue FS; Li P; Liao X; Li CW; Xu YC; Liu Y; Liu KP; Sun HT
    Acta Anaesthesiol Taiwan; 2007 Mar; 45(1):9-14. PubMed ID: 17424753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Onset time and duration of action of neuromuscular block induced by increasing doses of vecuronium bromide].
    Russo R; Veschi G; Dellino E; Ciceri R; Iapichino G
    Minerva Anestesiol; 1993; 59(1-2):35-8. PubMed ID: 8097304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuromuscular blockade following high-dose vecuronium administration].
    Otagiri T; Nishizawa M; Narita M; Kiyono S
    Masui; 1990 Feb; 39(2):174-83. PubMed ID: 1969971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The dose-response relationship and time course of the neuromuscular blockade by alcuronium].
    Pühringer F; Adler R; Mitterschiffthaler G; Koller J; Mair P; Khünl-Brady KS; Agoston S
    Anaesthesist; 1990 Oct; 39(10):508-12. PubMed ID: 1980578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.
    Ali HH; Savarese JJ; Basta SJ; Sunder N; Gionfriddo M
    Br J Anaesth; 1983; 55 Suppl 1():107S-111S. PubMed ID: 6134539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of neuromuscular blocking agents in patients undergoing renal transplantation under general anesthesia.
    Ma H; Zhuang X
    Chin Med J (Engl); 2002 Nov; 115(11):1692-6. PubMed ID: 12609090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of large doses of vecuronium; duration of initial and additional doses].
    Ueda N; Muteki T; Inoue S; Tsuda H; Katayama T; Morinaga T
    Masui; 1989 Nov; 38(11):1480-5. PubMed ID: 2573743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacodynamics of vecuronium in the kidney transplant recipient and the patient with normal renal function].
    Takita K; Goda Y; Kawahigashi H; Okuyama A; Kubota M; Kemmotsu O
    Masui; 1993 Feb; 42(2):190-4. PubMed ID: 8094765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
    Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of neuromuscular action of rocuronium, a new steroidal non-depolarizing agent, with vecuronium.
    Lin PL; Liu CC; Fan SZ; Chao A; Shin SC; Tai YT
    Acta Anaesthesiol Sin; 1997 Sep; 35(3):127-31. PubMed ID: 9407675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacokinetic explanation for increasing recovery time following larger or repeated doses of nondepolarizing muscle relaxants.
    Fisher DM; Rosen JI
    Anesthesiology; 1986 Sep; 65(3):286-91. PubMed ID: 2875680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A close relationship between post-tetanic twitch and train-of-four responses during neuromuscular blockade by vecuronium.
    Toyooka H; Noguchi Y; Ebata T; Amaha K
    J Anesth; 1991 Apr; 5(2):146-52. PubMed ID: 15278648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does intravenous infusion of nitroglycerin potentiate pancuronium- and vecuronium-induced neuromuscular blockade?
    Schwarz S; Agoston S; Houwertjes MC
    Anesth Analg; 1986 Feb; 65(2):156-60. PubMed ID: 2867718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic interaction between pantoprazole and vecuronium at neuromuscular junction.
    Vadgama VK; Patel YA; Patel TK; Tripathi CB
    Auton Autacoid Pharmacol; 2011; 31(1-2):31-5. PubMed ID: 21342416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the onset time, duration of action, and fade characteristics of atracurium and vecuronium.
    Haines M
    AANA J; 1993 Dec; 61(6):592-6. PubMed ID: 7903505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of vecuronium-induced neuromuscular block can be predicted by change of skin temperature over the thenar muscles.
    Suzuki T; Kitajima O; Watanabe A; Nonaka H; Saeki S; Ogawa S
    J Anesth; 2004; 18(3):172-6. PubMed ID: 15290414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of betamethasone on neuromuscular blockade induced by vecuronium in continuous infusion].
    Nocente M; Colcerasa P; Zema M; Bellomonte L; Vecchia P; Sanfilippo M
    Minerva Anestesiol; 1994 Nov; 60(11):687-92. PubMed ID: 7761019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.